Schraffordt Koops HS - Search Results

1

The protective potential of the combination of verapamil and cimetidine on cisplatin-induced nephrotoxicity in man.

Sleijfer DT, Offerman JJ, Mulder NH, Verweij M, van der Hem GK, Schraffordt Koops HS, Meijer S. Sleijfer DT, et al. Among authors: schraffordt koops hs. Cancer. 1987 Dec 1;60(11):2823-8. doi: 10.1002/1097-0142(19871201)60:11<2823::aid-cncr2820601138>3.0.co;2-c. Cancer. 1987. PMID: 3677015

2

Dacarbazine (DTIC), human recombinant interferon alpha 2a (Roferon) and 5-fluorouracil for disseminated malignant melanoma.

Mulder NH, de Vries EG, Sleijfer DT, Schraffordt Koops H, Willemse PH. Mulder NH, et al. Br J Cancer. 1992 Feb;65(2):303-4. doi: 10.1038/bjc.1992.61. Br J Cancer. 1992. PMID: 1739635 Free PMC article. No abstract available.

3

Phase II study of carboplatin and cytosine arabinoside in patients with disseminated malignant melanoma.

Mulder NH, Sleijfer DT, de Vries EG, Schraffordt Koops H, Willemse PH. Mulder NH, et al. J Cancer Res Clin Oncol. 1990;116(3):301-2. doi: 10.1007/BF01612907. J Cancer Res Clin Oncol. 1990. PMID: 2196265

4

Dacarbazine (DTIC) and human recombinant interferon alpha 2a (Roferon) in the treatment of disseminated malignant melanoma.

Mulder NH, Willemse PH, Schraffordt Koops H, de Vries EG, Sleijfer DT. Mulder NH, et al. Br J Cancer. 1990 Dec;62(6):1006-7. doi: 10.1038/bjc.1990.427. Br J Cancer. 1990. PMID: 2257203 Free PMC article. No abstract available.

5

The influence of verapamil on renal function in patients treated with cisplatin.

Offerman JJ, Meijer S, Sleijfer DT, Mulder NH, Donker AJ, Schraffordt Koops H, van der Hem GK. Offerman JJ, et al. Clin Nephrol. 1985 Nov;24(5):249-55. Clin Nephrol. 1985. PMID: 2416501

6

Phase II study of bleomycin, dacarbazine (DTIC) and vindesine in disseminated malignant melanoma.

Mulder NH, Sleijfer DT, de Vries EG, Schraffordt Koops H, Samson MJ, Willemse PH. Mulder NH, et al. J Cancer Res Clin Oncol. 1989;115(1):93-5. doi: 10.1007/BF00391607. J Cancer Res Clin Oncol. 1989. PMID: 2466036

7

The effect of captopril on renal function in patients during the first cis-diamminedichloroplatinum II infusion.

Offerman JJ, Sleijfer DT, Mulder NH, Meijer S, Schraffordt Koops H, Donker AJ. Offerman JJ, et al. Cancer Chemother Pharmacol. 1985;14(3):262-4. doi: 10.1007/BF00258130. Cancer Chemother Pharmacol. 1985. PMID: 3888432

8

Nephrotoxicity of cis-diamminedichloride platinum (CDDP) during remission-induction and maintenance chemotherapy of testicular carcinoma.

Meijer S, Mulder NH, Sleijfer DT, de Jong PE, Sluiter WJ, Schraffordt Koops H, van der Hem GK. Meijer S, et al. Cancer Chemother Pharmacol. 1982;8(1):27-30. doi: 10.1007/BF00292867. Cancer Chemother Pharmacol. 1982. PMID: 7201356

9

Decrease in pulmonary function during bleomycin-containing combination chemotherapy for testicular cancer: not only a bleomycin effect.

Sleijfer S, van der Mark TW, Schraffordt Koops H, Mulder NH. Sleijfer S, et al. Br J Cancer. 1995 Jan;71(1):120-3. doi: 10.1038/bjc.1995.24. Br J Cancer. 1995. PMID: 7529523 Free PMC article. Clinical Trial.

10

Enhanced effects of bleomycin on pulmonary function disturbances in patients with decreased renal function due to cisplatin.

Sleijfer S, van der Mark TW, Schraffordt Koops H, Mulder NH. Sleijfer S, et al. Eur J Cancer. 1996 Mar;32A(3):550-2. doi: 10.1016/0959-8049(95)00644-3. Eur J Cancer. 1996. PMID: 8814706 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

232 results

Search Page

Filters